Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2025-12-25 @ 2:04 PM
NCT ID:
NCT00112866
Group ID:
EG000
Title:
Post-Operative 2000mg
Description:
Postoperative Treatment: Beginning within 2 weeks after surgery, all patients receive high-dose 2000mg cilengitide IV over 1 hour twice weekly for 4 weeks. Treatment repeats every 4 weeks for up to 24 courses in the absence of disease progression or unacceptable toxicity.
cilengitide: Given IV
therapeutic conventional surgery: Undergo tumor resection
pharmacological study: Correlative studies
laboratory biomarker analysis: Correlative studies
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
26
Other Number Affected:
26
Other Number At Risk:
26
Study:
NCT00112866
Results Section:
NCT00112866
Adverse Events Module:
NCT00112866